Sign in

CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843199512
Phone
(214) 612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. UPLOAD Other SEC-generated Letter
  3. S-3 Offering Registration Statement
  4. 8-K Event Other events
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. 4 Insider Changes in Ownership
  8. D Other Notice of Sales of Unregistered Securities
  9. SC 13G Stake Amended Statement of Ownership
  10. 144 Insider Sale of Securities
  11. 8-K Event Other events
  12. SC 13D/A Stake Beneficial Ownership Report
  13. SC 13D/A Stake Beneficial Ownership Report
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 10-Q Report Quarterly Report
  19. 8-K Event Material agreement · Results of operations · Unregistered share sale · Other events
  20. 8-K Event Delisting notice

Page 10 of 21 · 403 filings